WORKING TOGETHER
Stegram Pharmaceuticals has a rich heritage of working within the UK since our first facility was opened back in 1989.
Over the past 30 years, we have continued to invest in the UK and are committed to working with the NHS and other healthcare organisations across the industry developing solutions to improve the delivery of care and patient outcomes.
In 2020, we spent over £250 million supporting research and development carried out in the UK and contributed to 162 collaborations with universities, pharmaceutical companies, industries and others. Through collaborations with scientists, academics and clinicians, sharing knowledge, skills and expertise we aim to improve the health and lives of people in the UK and around the world. During 2020, we had 55 clinical trials on-going in the UK, across 292 UK sites, involving over 4,000 patients since the trials started.